Leo Pharma wants to be first in US with hand eczema treatment

After securing fast-track status from the FDA, Leo Pharma hopes to become the first company in the US to specifically address chronic hand eczema, for which there is no treatment in the country.

Photo: Leo Pharma / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles